NC

Nilkanth Chandulal Thakkar

Active Director Director DIN 08206155
DIN 08206155 First appointment Aug 2018 Primary industry Professional Services
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Total affiliations 4 Since Aug 2018
Shareholding value •••• Premium profile

About Nilkanth Chandulal Thakkar

Data last updated:

Nilkanth Chandulal Thakkar is a Director at Akshar Global Clinical Research Private Limited (since 2023), Director at Prm Refractories & Metals Private Limited (since 2018) and Director at Alevigen Biosciences Private Limited (since 2026), and holds 1 more current directorship. The companies operate in Professional Services, Manufacturing and Biotechnology. The 2 current companies with reported revenue have a combined latest revenue of ₹16,750; the largest is Akshar Global Clinical Research Private Limited at ₹10,000 (FY 2024).

DIN 08206155
Primary Designation Director
Industry Professional Services
First Appointment 24 Aug 2018
Oldest Company Age 8 yrs
Largest company Akshar Global Clinical Research Private Limited · ₹10,000 (FY 2024)
Combined revenue ₹16,750 across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director18 May 20232023₹10,000 (FY 2024)Active
Director24 Aug 20182018₹6,750 (FY 2025)Active
Alevigen Biosciences Private Limited U72100GJ2026PTC171571
Director02 Jan 20262026Active
Director26 Mar 20252025Active

Directorship timeline

Open interactive timeline →
Prm Refractories & Metals Private Limited
Akshar Global Clinical Research Private Limited
Alevigen Biosciences Private Limited
Pramukh Global Organics Private Limited
Premium access

Shareholding and investment profile for Nilkanth Chandulal Thakkar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nilkanth Chandulal Thakkar

Nilkanth Chandulal Thakkar currently holds 4 directorships: Akshar Global Clinical Research Private Limited (Director, since 18 May 2023, revenue ₹10,000 (FY 2024)); Prm Refractories & Metals Private Limited (Director, since 24 Aug 2018, revenue ₹6,750 (FY 2025)); Alevigen Biosciences Private Limited (Director, since 02 Jan 2026); Pramukh Global Organics Private Limited (Director, since 26 Mar 2025).

Nilkanth Chandulal Thakkar was first appointed on 24 Aug 2018 as Director at Prm Refractories & Metals Private Limited. The most recent appointment on record is 02 Jan 2026 at Alevigen Biosciences Private Limited.

The 2 current companies of Nilkanth Chandulal Thakkar that report revenue have a combined latest revenue of ₹16,750: Akshar Global Clinical Research Private Limited ₹10,000 (FY 2024); Prm Refractories & Metals Private Limited ₹6,750 (FY 2025).

The current boards of Nilkanth Chandulal Thakkar's companies include Bansal Atulkumar Thakkar (Akshar Global Clinical Research Private Limited), Mangesh Sukhdeorao Shende (Akshar Global Clinical Research Private Limited), Raj Bipinbhai Thakkar (Akshar Global Clinical Research Private Limited), Rekhaben Thakkar (Prm Refractories & Metals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available